scispace - formally typeset
E

Ewan A. Gibb

Researcher at BC Cancer Agency

Publications -  100
Citations -  10379

Ewan A. Gibb is an academic researcher from BC Cancer Agency. The author has contributed to research in topics: Bladder cancer & Medicine. The author has an hindex of 29, co-authored 80 publications receiving 7401 citations. Previous affiliations of Ewan A. Gibb include University of Western Ontario & University of British Columbia.

Papers
More filters
Journal ArticleDOI

Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer

A. Gordon Robertson, +170 more
- 19 Oct 2017 - 
TL;DR: An analysis of 412 muscle-invasive bladder cancers characterized by multiple TCGA analytical platforms identified 5 expression subtypes that may stratify response to different treatments and identified a poor-survival "neuronal" subtype in which the majority of tumors lacked small cell or neuroendocrine histology.
Journal ArticleDOI

The functional role of long non-coding RNA in human carcinomas

TL;DR: The emerging functional role of lncRNAs in human cancer is highlighted and molecular mechanisms by which these RNA species function are described, providing insight into the functional roles they may play in tumorigenesis.
Journal ArticleDOI

Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma

Benjamin J. Raphael, +265 more
- 14 Aug 2017 - 
TL;DR: An integrated multi-platform analysis of 150 pancreatic ductal adenocarcinoma specimens reveals a complex molecular landscape of PDAC and provides a roadmap for precision medicine.
Journal ArticleDOI

A Consensus Molecular Classification of Muscle-invasive Bladder Cancer.

TL;DR: In this paper, a consensus set of six molecular classes (luminal papillary (24%), luminal nonspecified (8), luminal unstable (15), stroma-rich (15%), basal/squamous (35%), and neuroendocrine-like (3%) was identified.
Journal ArticleDOI

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

TL;DR: Comprehensive genomic and phenotypic analysis of the RCC subtypes reveals distinctive features of each subtype that provide the foundation for the development of subtype-specific therapeutic and management strategies for patients affected with these cancers.